Company Overview - Sigyn Therapeutics, Inc. is focused on developing dialysis-like therapies aimed at treating cardiovascular disease and cancer [6] - The company's flagship technology, Sigyn CardioDialysisTM, is designed to purify blood by reducing inflammatory molecules and targeting cholesterol transporting lipoproteins, which are linked to major adverse cardiovascular events [6] - Sigyn Therapeutics has a development pipeline that includes ImmunePrep(TM) for optimizing immunotherapeutic antibody delivery, ChemoPrep(TM) for enhancing chemotherapy delivery, and ChemoPure(TM) for reducing chemotherapy toxicity [6] Event Details - Sigyn Therapeutics will present at the LD Micro Main Event XIX on October 21st at 4:00 PM PT in San Diego, California [1] - The LD Micro Main Event XIX will take place from October 19th to 21st, featuring around 120 companies presenting in half-hour increments [4][5] - The event will include keynote speakers, company presentations, and one-on-one investor meetings, concluding with a closing reception [4]